Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: Relationship to disease manifestations and activity

International Journal of Rheumatic Diseases

Volumn 14, Issue 4, 2011, Pages 325-331

  Hassan, Samia Z ^a   Gheita, Tamer A ^a   Kenawy, Sanaa A ^b   Fahim, Atef T ^b   El Sorougy, Iman M ^a   Abdou, Manal S ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Antioxidants; Glutathione; Glutathione peroxidase; Lipid peroxidation; Malondialdehyde; Oxidative stress; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROXYCHLOROQUINE; MALONALDEHYDE; METHOTREXATE; STEROID;

ADULT; ALOPECIA; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HEALTH STATUS; HUMANS; JOINTS; LIPID PEROXIDATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; OXIDOREDUCTASES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 80054699494     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01630.x     Document Type: Article

References (54)

1. Ku IA, Imboden JB, Hsue PY, Ganz P (2009) Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis. Circ J 73, 977-85.
2. Rho YH, Chung CP, Oeser A, et al. (2010) Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res (Hoboken) 62, 1473-80.
3. Khan F, Siddiqui AA (2006) Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Clin Chim Acta 370, 100-7.
4. Leitinger N (2008) The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans. Subcell Biochem 49, 325-50.
5. Mansour RB, Lassoued S, Gargouri B, El Gaïd A, Attia H, Fakhfakh F (2008) Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol 37, 103-8.
6. Altindag O, Karakoc M, Kocyigit A, Celik H, Soran N (2007) Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem 40, 167-171.
7. Pedersen-Lane JH, Zurier RB, Lawrence DA (2007) Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients. J Leukoc Biol 81, 934-41.
8. Kalpakcioglu B, Senel K (2008) The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol 27, 141-5.
9. Vasanthi P, Nalini G, Rajasekhar G (2009) Status of oxidative stress in rheumatoid arthritis. Int J Rheum Dis 12, 29-33.
10. Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D (2006) High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin Chim Acta 367, 156-61.
11. Hitchon CA, El-Gabalawy HS (2004) Oxidation in rheumatoid arthritis. Arthritis Res Ther 6, 265-78.
12. Baskol G, Demir H, Baskol M, et al. (2005) Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 38, 951-5.
13. Griffiths HR (2005) ROS as signalling molecules in T cells - evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox Rep 10, 273-80.
14. Jaswal S, Mehta HC, Sood AK, Kaur J (2003) Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 338, 123-9.
15. Mirshafiey A, Mohsenzadegan M (2008) The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. Iran J Allergy Asthma Immunol 7, 195-202.
16. Esteves Martins Mde F, Carvalho R, Alves M, Monteiro da Silva Ferreira CA, Pires Bicho MD (2008) Genetic polymorphisms of low molecular weight protein tyrosine phosphatase (LMW-PTP): relationship with erythrocyte enzymatic phenotype in patients with Systemic Lupus Erythematosus. Acta Reumatol Port 33, 177-87.
17. Perl A (2009) Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 21, 443-7.
18. Kang TY, El-Sohemy A, Comelis MC, Eny KM, Bae SC (2005) Glutathione S-transferase genotype and risk of systemic lupus erythematosus in Koreans. Lupus 14, 381-4.
19. Sheikh Z, Ahmad R, Sheikh N, Ali R (2007) Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 40, 512-20.
20. Wang G, Pierangeli SS, Papalardo E, Ansari GA, Khan MF (2010) Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum 62, 2064-72.
21. Ben Mansour R, Lassoued S, Elgaied A, et al. (2010) Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol 39, 247-53.
22. Alves JD, Grima B (2003) Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis. Curr Rheumatol Rep 5, 383-90.
23. Lopez LR, Simpson DF, Hurley BL, Matsuura E (2005) OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Ann N Y Acad Sci 1051, 313-22.
24. Perl A (2010) Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity 43, 1-6.
25. Tewthanom K, Janwityanuchit S, Totemchockchyakarn K, Panomvana D (2008) Correlation of lipid peroxidation and glutathione levels with severity of systemic lupus erythematosus: a pilot study from single center. J Pharm Pharm Sci 11, 30-4.
26. Chung CP, Titova D, Oeser A, et al. (2009) Oxidative stress in fibromyalgia and its relationship to symptoms. Clin Rheumatol 28, 435-8.
27. Coaccioli S, Panaccione A, Biondi R, et al. (2009) Evaluation of oxidative stress in rheumatoid and psoriatic arthritis and psoriasis. Clin Ter 160, 467-72.
28. Pattison DJ, Winyard PG (2008) Dietary antioxidants in inflammatory arthritis: do they have any role in etiology or therapy? Nat Clin Pract Rheumatol 4, 590-6.
29. Costenbader KH, Kang JH, Karlson EW (2010) Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol 172, 205-16.
30. Filippin LI, Vercelino R, Marroni NP, Xavier RM (2008) Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 152, 415-22.
31. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40, 1725.
32. Aletaha D, Neogi T, Silman AJ, et al. (2010) 2010 Rheumatoid arthritis classification criteria an American College of Rheumatology/European League Against Rheumatism. Arthritis Rheum 62, 2569-81.
33. Bombardier C, Gladman D, Urowitz M, Caron D, Chang C (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35, 630-40.
34. Prevoo MLL, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM (1995) Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38, 44-8.
35. Gladman D, Ginzler E, Goldsmith C, et al. (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39, 363-9.
36. Uchiyama M, Mihara M (1978) Determination of malonaldehyde precursor in tissue by thiobarbituric acid test. Anal Biochem 86, 271-8.
37. Beutler E, Duron O, Kelley BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61, 882-8.
38. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70, 158.
39. Taysi S, Polat F, Gul M, Sari RA, Bakan E (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21, 200-4.
40. Ozkan Y, Yardým-Akaydýn S, Sepici A, Keskin E, Sepici V, Simsek B (2007) Oxidative status in rheumatoid arthritis. Clin Rheumatol 26, 64-8.
41. Cimen MY, Cimen OB, Kaçmaz M, Oztürk HS, Yorgancioǧlu R, Durak I (2000) Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 19, 275-7.
42. Shah D, Kiran R, Wanchu A, Bhatnagar A (2010) Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol Lett 129, 7-12.
43. Zhang Q, Ye DQ, Chen GP, Zheng Y (2010) Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin Exp Dermatol 35, 287-94.
44. Gergely P Jr, Grossman C, Niland B, et al. (2002) Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 46, 175-90.
45. Morgan PE, Sturgess AD, Davies MJ (2009) Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res 43, 117-27.
46. Huang WN, Tso TK, Huang HY (2007) Enhanced oxidative status but not corresponding elevated antioxidative status by anticardiolipin antibody and disease activity in patients with systemic lupus erythematosus. Rheumatol Int 27, 453-8.
47. Avalos I, Chung CP, Oeser A, et al. (2007) Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus 16, 195-200.
48. Morgan PE, Sturgess AD, Hennessy A, Davies MJ (2007) Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis. Free Radic Res 41, 1301-12.
49. Moodley D, Mody G, Patel N, Chuturgoon AA (2008) Mitochondrial depolarisation and oxidative stress in rheumatoid arthritis patients. Clin Biochem 41 (16-17), 1396-401.
50. Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38, 981-6.
51. Seven A, Güzel S, Aslan M, Hamuryudan V (2008) Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem 41, 538-43.
52. Ames PR, Alves J, Murat I, Isenberg DA, Nourooz-Zadeh J (1999) Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement. Rheumatology (Oxford) 38, 529-34.
53. Matyska-Piekarska E, Łuszczewski A, Łacki J, Wawer I (2006) The role of oxidative stress in the etiopathogenesis of rheumatoid arthritis. Postepy Hig Med Dosw (Online) 60, 617-23.
54. Herman S, Zurgil N, Deutsch M (2005) Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm Res 54, 273-80.